phase i trial of copanlisib nivolumab in patients with richter’s transformation or transformed fl
Published 6 months ago • 35 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
2:25
the safety & efficacy of copanlisib nivolumab in patients with rt and tnhl: a chemo-free approach
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
1:35
update on phase i study of plamotamab in r/r nhl
-
3:09
phase i trial results for nivolumab and pembrolizumab in lymphoma and multiple myeloma
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl
-
1:44
updates from the phase ii animate trial of nivolumab in r/r chl
-
2:44
how is immunotherapy used to fight cancer? | dana-farber cancer institute | science illustrated
-
1:19:17
an insider's look: innovations in malignant hematology research
-
1:21:44
cell blocks and ihc in cytopathology
-
2:22
epcore cll-1: phase i trial of epcoritamab in r/r cll
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
7:51
phase i study shows nivolumab is safe and tolerable for relapsed or refractory hodgkin lymphoma
-
1:58
ash highlights: glofitamab in dlbcl & pirtobrutinib and epcoritamab in richter's transformation
-
1:56
updated results of phase i/ii bruin study: pirtobrutinib in covalent btk inhibitor pretreated mcl
-
2:15
updates from the phase ii aern trial: nivolumab and radiotherapy for the treatment of r/r hl
-
1:46
phase i study of costimulatory bispecific antibody ro7227166 combined with glofitamab in r/r b-nhl
-
2:02
phase ii animate trial investigating pet response-adapted treatment using nivolumab in r/r chl
-
1:22
phase i study of ioa-244 in follicular lymphoma
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll